The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer

In the evolving molecular landscape of metastatic colorectal cancer, optimizing available tools to select patients to receive anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies is a modern challenge of colorectal oncologists. Several molecular biomarkers have been investigated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoniotti, Carlotta, Ongaro, Elena, Falcone, Alfredo, Cremolini, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121538/
https://www.ncbi.nlm.nih.gov/pubmed/30081606
http://dx.doi.org/10.3390/ijms19082298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121538/
https://www.ncbi.nlm.nih.gov/pubmed/30081606
http://dx.doi.org/10.3390/ijms19082298

Ejemplares similares